Compounds > 2-fluoro-2',3'-dideoxyadenosine
Page last updated: 2024-08-25

2-fluoro-2',3'-dideoxyadenosine and HIV

2-fluoro-2',3'-dideoxyadenosine has been researched along with HIV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donzanti, BA; Driscoll, JS; Kelley, JA; Placke, M; Roth, JS; Singer, A; Tomaszewski, JE; Tosca, P; Yarrington, JT1
Carrera, CJ; Carson, DA; Haertle, T; Richman, DD; Sowers, LC; Wasson, DB1

Other Studies

2 other study(ies) available for 2-fluoro-2',3'-dideoxyadenosine and HIV

ArticleYear
Acute cardiotoxicity of the Anti-HIV dideoxynucleoside, F-ddA, in the rat.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1995, Volume: 27, Issue:2

    Topics: Administration, Oral; Animals; Antiviral Agents; Chromatography, High Pressure Liquid; Dideoxyadenosine; Female; Heart Diseases; HIV; Injections, Intravenous; Myocardium; Rats; Rats, Sprague-Dawley

1995
Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2',3'-dideoxyadenosine derivatives.
    The Journal of biological chemistry, 1988, Apr-25, Volume: 263, Issue:12

    Topics: Adenosine Deaminase Inhibitors; AMP Deaminase; Cell Line; Coformycin; Deoxyadenosines; Deoxycytidine Kinase; Dideoxyadenosine; Dideoxynucleosides; HIV; Humans; Phosphorylation; T-Lymphocytes; Virus Replication

1988